|
⚲
|
| Keyboard |
| McLeod Howard
✚
|
|
|---|---|
| CIK # | 0001627816 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001627816] | |
| 4 | [0001627816] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McLeod Howard | |
| Cancer Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-03-30 | Grant | 43,478 | ||
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Grant | 13,015 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2019-07-23 | Grant | 100,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-09-28 | Grant | 5,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-09-28 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-06-07 | Grant | 10,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-06-07 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2016-10-11 | Grant | 10,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-10-11 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-03-17 | Buy | 1,000 | $2.71 | 2,710 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2015-05-14 | Grant | 5,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2015-05-14 | Grant | 10,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2014-12-11 | Grant | 5,000 | $0.00 |